Mika Mustonen

1.3k total citations
49 papers, 1.1k citations indexed

About

Mika Mustonen is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mika Mustonen has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Genetics and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mika Mustonen's work include Estrogen and related hormone effects (19 papers), Prostate Cancer Treatment and Research (17 papers) and Hormonal and reproductive studies (8 papers). Mika Mustonen is often cited by papers focused on Estrogen and related hormone effects (19 papers), Prostate Cancer Treatment and Research (17 papers) and Hormonal and reproductive studies (8 papers). Mika Mustonen collaborates with scholars based in Finland, United Kingdom and France. Mika Mustonen's co-authors include Matti Poutanen, Veli Isomaa, Reijo Vihko, Pirkko Vihko, Minna Miettinen, Karim Fizazi, Christophe Massard, John Aspegrén, Katja Porvari and Atte P. Kyllönen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mika Mustonen

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mika Mustonen Finland	17	456	436	368	300	148	49	1.1k
JC Diaz-Chico Spain	18	207 0.5×	149 0.3×	364 1.0×	91 0.3×	76 0.5×	51	1.1k
Yvan Labrie Canada	22	410 0.9×	325 0.7×	615 1.7×	95 0.3×	67 0.5×	43	1.1k
Tarja Ikonen Finland	20	817 1.8×	446 1.0×	889 2.4×	704 2.3×	54 0.4×	44	1.7k
Gerard A. Tarulli Australia	19	431 0.9×	92 0.2×	456 1.2×	211 0.7×	255 1.7×	30	1.2k
Vessela N. Kristensen Norway	23	533 1.2×	114 0.3×	751 2.0×	138 0.5×	82 0.6×	49	1.4k
Jos Veldscholte Netherlands	17	926 2.0×	797 1.8×	1.1k 3.0×	1.3k 4.4×	82 0.6×	20	2.3k
Guy Verrijdt Belgium	24	823 1.8×	478 1.1×	886 2.4×	498 1.7×	113 0.8×	31	1.5k
Patrick Kwok‐Shing Ng United States	17	158 0.3×	191 0.4×	610 1.7×	419 1.4×	41 0.3×	38	1.2k
Cheng-Lung Hsu Taiwan	12	275 0.6×	130 0.3×	411 1.1×	323 1.1×	27 0.2×	15	759
Elizabeth Anderson United Kingdom	20	1.1k 2.4×	149 0.3×	627 1.7×	277 0.9×	56 0.4×	44	1.9k

Countries citing papers authored by Mika Mustonen

Since Specialization

Citations

This map shows the geographic impact of Mika Mustonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Mustonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Mustonen more than expected).

Fields of papers citing papers by Mika Mustonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Mustonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Mustonen. The network helps show where Mika Mustonen may publish in the future.

Co-authorship network of co-authors of Mika Mustonen

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Mustonen. A scholar is included among the top collaborators of Mika Mustonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Mustonen. Mika Mustonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iivanainen, Sanna, et al.. (2024). 81P FINPROVE: The Finnish national study to facilitate patient access to targeted anti-cancer drugs – Preliminary data after two years of enrollment. Annals of Oncology. 35. S246–S246. 1 indexed citations

Peltola, Katriina, Petri Bono, Robert H. Jones, et al.. (2018). ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer. European Urology Focus. 6(1). 63–70. 5 indexed citations

Oksala, Riikka, Matias Knuuttila, Arfa Mehmood, et al.. (2018). Adrenals Contribute to Growth of Castration-Resistant VCaP Prostate Cancer Xenografts. American Journal Of Pathology. 188(12). 2890–2901. 18 indexed citations

Oksala, Riikka, Reetta Riikonen, Petteri Rummakko, et al.. (2018). Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1. The Journal of Steroid Biochemistry and Molecular Biology. 192. 105115–105115. 16 indexed citations

Oksala, Riikka, Reetta Riikonen, Petteri Rummakko, et al.. (2017). ODM-208, a novel CYP11A1-inhibitor as a therapeutic approach for the treatment of castration-resistant prostate cancer. Annals of Oncology. 28. v8–v8. 2 indexed citations

Fizazi, Karim, Christophe Massard, Petri Bono, et al.. (2017). Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Castration-resistant, CYP17 Inhibitor-naïve Prostate Cancer: Results from Extended Follow-up of the ARADES Trial. European Urology Focus. 3(6). 606–614. 17 indexed citations

Pelkonen, Paavo, Mika Mustonen, Antti Asikainen, et al.. (2014). What Science Can Tell Us: Forest Bioenergy for Europe. IIASA PURE (International Institute of Applied Systems Analysis). 6 indexed citations

Mustonen, Mika. (2014). Toremifene in the treatment of breast cancer. World Journal of Clinical Oncology. 5(3). 393–393. 30 indexed citations

Fizazi, Karim, Christophe Massard, Petri Bono, et al.. (2014). Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial. The Lancet Oncology. 15(9). 975–985. 154 indexed citations

10.

Pitkin, Joan, et al.. (2007). Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women. Menopause international. 13(3). 116–123. 17 indexed citations

11.

Mattsson, L.‐Å., Sven O. Skouby, Margaret Rees, et al.. (2007). Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women. Menopause international. 13(3). 124–131. 12 indexed citations

12.

Zhou, Yinghui, John Whitehead, Pasi Korhonen, & Mika Mustonen. (2007). Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers. Biometrics. 64(1). 299–308. 7 indexed citations

13.

Erkkola, Risto, Leena Mattila, T.J. Powles, et al.. (2005). Bone Mineral Density and Lipid Changes During 5 Years of Follow-up in a Study of Prevention of Breast Cancer with Toremifene in Healthy, High-risk Pre- and Post-menopausal Women. Breast Cancer Research and Treatment. 93(3). 277–287. 12 indexed citations

14.

Erkkola, Risto, et al.. (2004). No increased risk of endometrial hyperplasia with fixed long-cycle oestrogen-progestogen therapy after five years. The Journal of the British Menopause Society. 10(1). 9–13. 10 indexed citations

15.

Erkkola, Risto, et al.. (2002). No increased risk of endometrial hyperplasia with fixed long-cycle hormone replacement therapy after two years. The Journal of the British Menopause Society. 8(4). 155–156. 2 indexed citations

16.

Sipilä, Petra, Trevor G. Cooper, Ching‐Hei Yeung, et al.. (2002). Epididymal Dysfunction Initiated by the Expression of Simian Virus 40 T-Antigen Leads to Angulated Sperm Flagella and Infertility in Transgenic Mice. Molecular Endocrinology. 16(11). 2603–2617. 49 indexed citations

17.

Mustonen, Mika, et al.. (1999). Primary Structure of a Sperm Cell Anion Exchanger and its Messenger Ribonucleic Acid Expression During Spermatogenesis. Biology of Reproduction. 61(4). 981–986. 23 indexed citations

18.

Miettinen, Minna, Mika Mustonen, Matti Poutanen, et al.. (1999). 17β‐hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Research and Treatment. 57(2). 175–182. 55 indexed citations

19.

Vaarala, Markku H., Katja Porvari, Atte P. Kyllönen, et al.. (1998). Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: Confirmation of L7a and L37 over-expression in prostate-cancer tissue samples. International Journal of Cancer. 78(1). 27–32. 94 indexed citations

20.

Vaarala, Markku H., Katja Porvari, Atte P. Kyllönen, et al.. (1998). Several genes encoding ribosomal proteins are over‐expressed in prostate‐cancer cell lines: Confirmation of L7a and L37 over‐expression in prostate‐cancer tissue samples. International Journal of Cancer. 78(1). 27–32. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact